Breast Cancer Version 2.2015.

Published

Journal Article

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This portion of the NCCN Guidelines discusses recommendations specific to the locoregional management of clinical stage I, II, and IIIA (T3N1M0) tumors.

Full Text

Duke Authors

Cited Authors

  • Gradishar, WJ; Anderson, BO; Balassanian, R; Blair, SL; Burstein, HJ; Cyr, A; Elias, AD; Farrar, WB; Forero, A; Giordano, SH; Goetz, M; Goldstein, LJ; Hudis, CA; Isakoff, SJ; Marcom, PK; Mayer, IA; McCormick, B; Moran, M; Patel, SA; Pierce, LJ; Reed, EC; Salerno, KE; Schwartzberg, LS; Smith, KL; Smith, ML; Soliman, H; Somlo, G; Telli, M; Ward, JH; Shead, DA; Kumar, R

Published Date

  • April 2015

Published In

Volume / Issue

  • 13 / 4

Start / End Page

  • 448 - 475

PubMed ID

  • 25870381

Pubmed Central ID

  • 25870381

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States